Schedule 13D ownership disclosure
ADAPTIN BIO, INC.
Common Stock, par value $0.0001 per share · CUSIP: 00654M100
Event date: 2025-02-11
- Filing-level shares
- 928,571.00
- Percent of class
- 11.5%
- Simon PedderReported CIK 0001316736
Shares: 928,571.00 · Class: 11.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-014977
- Form type
- SCHEDULE 13D
- Filer
- ADAPTIN BIO, INC.
- CIK
- CIK 1938571
- Filed
- Feb 18, 2025
- Reporting period
- Feb 11, 2025
- Description
- Schedule 13D beneficial ownership